MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
51 hedge funds and large institutions have $54.8M invested in Mirati Therapeutics, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 17 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
-13
Holders Change %
-20.31%
% of All Funds
1.27%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
13
Reduced
17
Closed
23
Calls
$4K
Puts
$17K
Net Calls
-$13K
Net Calls Change
+$55K
Top Buyers
| 1 |
BC
Broadfin Capital
New York
|
+$1.46M |
| 2 |
RA
Royce & Associates
New York
|
+$431K |
| 3 |
ECM
Element Capital Management
New York
|
+$391K |
| 4 |
Millennium Management
New York
|
+$366K |
| 5 |
HP
Hikari Power
Tokyo,
Japan
|
+$365K |
Top Sellers
| 1 |
BlackRock
New York
|
-$2.14M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$1.96M |
| 3 |
GTC
Ghost Tree Capital
New York
|
-$895K |
| 4 |
Renaissance Technologies
New York
|
-$854K |
| 5 |
State Street
Boston,
Massachusetts
|
-$721K |
